Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2001;32:1793-1799

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hankey, G. J.
Right arrow Articles by Baker, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hankey, G. J.
Right arrow Articles by Baker, R. I.
Related Collections
Right arrow Arterial thrombosis
Right arrow Coagulation
Right arrow Thrombophilia
Right arrow Risk Factors
Right arrow Acute Cerebral Infarction

(Stroke. 2001;32:1793.)
© 2001 American Heart Association, Inc.


Original Contributions

Inherited Thrombophilia in Ischemic Stroke and Its Pathogenic Subtypes

Graeme J. Hankey, MBBS, MD, FRCP, FRCP(Edin), FRACP; John W. Eikelboom, MBBS, MSc, FRACP, FRCPA; Frank M. van Bockxmeer, BSc (Hons), PhD; Elizabeth Lofthouse, BSc (Hons); Nicole Staples, MBBS Ross I. Baker, MBBS, BMedSc, FRACP, FRCPA

From the Stroke Unit (G.J.H.), Department of Neurology, Royal Perth Hospital, Perth, Australia; Thrombosis and Haemophilia Service (J.W.E., E.L., N.S., R.I.B.), Royal Perth Hospital, Perth, Australia; and Cardiovascular Genetics Laboratory (F.M.v.B.), Clinical Pathology and Biochemistry, Royal Perth Hospital, and Department of Pathology, University of Western Australia, Perth, Australia.

Correspondence to John Eikelboom, Department of Haematology, Royal Perth Hospital, Box X2213 GPO, Perth WA 6001, Australia. E-mail johneikelboom{at}eftel.com.au

Background and Purpose— One or more of the inherited thrombophilias may be causal risk factor for a proportion of ischemic strokes, but few studies have addressed this association or the association between thrombophilia and pathogenic subtypes of stroke.

Methods— We conducted a case-control study of 219 hospital cases with a first-ever ischemic stroke and 205 randomly selected community control subjects stratified by age, sex, and postal code. With the use of established criteria, cases of stroke were classified by pathogenic subtype in a blinded fashion. The prevalence of conventional vascular risk factors; fasting plasma levels of protein C, protein S, antithrombin III; and genetic tests for the factor V Leiden and the prothrombin 20210A mutation were determined in cases and control subjects.

Results— The prevalence of any thrombophilia was 14.7% (95% CI, 9.9% to 19.5%) among cases and 11.7% (95% CI, 7.4% to 17.0%) among control subjects (OR, 1.3; 95% CI, 0.7% to 2.3%). The prevalence of individual thrombophilias among cases ranged from 0.9% (95% CI, 0.1% to 3.4%) for protein S deficiency to 5.2% (95% CI, 0.3% to 9.1%) for antithrombin III deficiency; among control subjects, the prevalence ranged from 1.0% (95% CI, 0.1% to 3.6%) for protein S deficiency to 4.1% (95% CI, 0.2% to 7.8%) for antithrombin III deficiency. There were no significant differences in the prevalence of thrombophilia between cases and control subjects or between pathogenic subtypes of ischemic stroke.

Conclusions— One in 7 patients with first-ever acute ischemic stroke will test positive for one of the inherited thrombophilias, but the relation is likely to be coincidental rather than causal in almost all cases, irrespective of the pathogenic subtype of the ischemic stroke. These results suggest that routine testing for thrombophilia in most patients with acute ischemic stroke may be unnecessary. Whether the thrombophilias may still be important in younger patients with ischemic stroke or in predicting complications (eg, venous thrombosis) and stroke outcome remains uncertain.


Key Words: cerebral infarction • stroke classification • thrombophilia




This article has been cited by other articles:


Home page
StrokeHome page
E. Berge, K. B. F. Haug, E. Charlotte Sandset, K. Kristine Haugbro, M. Turkovic, and P. M. Sandset
The Factor V Leiden, Prothrombin Gene 20210GA, Methylenetetrahydrofolate Reductase 677CT and Platelet Glycoprotein IIIa 1565TC Mutations in Patients With Acute Ischemic Stroke and Atrial Fibrillation
Stroke, March 1, 2007; 38(3): 1069 - 1071.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al.
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Circulation, June 20, 2006; 113(24): e873 - e923.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al.
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Stroke, June 1, 2006; 37(6): 1583 - 1633.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al.
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
Circulation, March 14, 2006; 113(10): e409 - e449.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al.
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
Stroke, February 1, 2006; 37(2): 577 - 617.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
F. J. Carod-Artal, S. V. Nunes, D. Portugal, T. V. F. Silva, and A. P. Vargas
Ischemic Stroke Subtypes and Thrombophilia in Young and Elderly Brazilian Stroke Patients Admitted to a Rehabilitation Hospital
Stroke, September 1, 2005; 36(9): 2012 - 2014.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. K. Lynch, C. J. Han, L. E. Nee, and K. B. Nelson
Prothrombotic Factors in Children With Stroke or Porencephaly
Pediatrics, August 1, 2005; 116(2): 447 - 453.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. Butler and R. Neilson
Thrombophilia Screening and Ischemic Stroke
Arch Intern Med, December 13, 2004; 164(22): 2502 - 2502.
[Full Text] [PDF]


Home page
Arch NeurolHome page
J. P. Casas, A. D. Hingorani, L. E. Bautista, and P. Sharma
Meta-analysis of Genetic Studies in Ischemic Stroke: Thirty-two Genes Involving Approximately 18 000 Cases and 58 000 Controls
Arch Neurol, November 1, 2004; 61(11): 1652 - 1661.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M-H Tsai, W-P Tsai, S-T Liao, and L-b Liou
Anticardiolipin antibodies in various diseases in Taiwan: a retrospective analysis
Lupus, October 1, 2003; 12(10): 747 - 753.
[Abstract] [PDF]


Home page
StrokeHome page
G. J. Hankey and J. W. Eikelboom
Editorial Comment--Routine Thrombophilia Testing in Stroke Patients Is Unjustified
Stroke, August 1, 2003; 34(8): 1826 - 1827.
[Full Text] [PDF]


Home page
StrokeHome page
P. Jerrard-Dunne, A. Evans, R. McGovern, C. Hajat, L. Kalra, A. G. Rudd, C. D. Wolfe, and H. S. Markus
Ethnic Differences in Markers of Thrombophilia: Implications for the Investigation of Ischemic Stroke in Multiethnic Populations: The South London Ethnicity and Stroke Study
Stroke, August 1, 2003; 34(8): 1821 - 1826.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
W.-H. Chen, M.-Y. Lan, Y.-Y. Chang, S.-S. Chen, and J.-S. Liu
The Prevalence of Protein C, Protein S, and Antithrombin III Deficiency in non-APS/SLE Chinese Adults with Noncardiac Cerebral Ischemia
Clinical and Applied Thrombosis/Hemostasis, April 1, 2003; 9(2): 155 - 162.
[Abstract] [PDF]


Home page
BloodHome page
K. Juul, A. Tybjarg-Hansen, R. Steffensen, S. Kofoed, G. Jensen, and B. G. Nordestgaard
Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses
Blood, June 17, 2002; 100(1): 3 - 10.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. D. Bushnell and L. B. Goldstein
Physician Knowledge and Practices in the Evaluation of Coagulopathies in Stroke Patients
Stroke, April 1, 2002; 33(4): 948 - 953.
[Abstract] [Full Text] [PDF]